Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study
- PMID: 28993818
- PMCID: PMC5630181
- DOI: 10.1016/j.bpsc.2017.03.019
Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study
Abstract
Background: Preclinical and postmortem studies have implicated the metabotropic glutamate receptor 5 (mGluR5) in the pathophysiology of major depressive disorder (MDD). The goal of the present study was to determine the role of mGluR5 in a large group of individuals with MDD compared to healthy controls (HC) in vivo with [18F]FPEB and positron emission tomography (PET). Furthermore, we sought to determine the role glutamate plays on mGluR5 availability in MDD.
Methods: Sixty-five participants (30 MDD and 35 HC) completed [18F]FPEB PET to estimate the primary outcome measure - mGluR5 volume of distribution (VT), and the secondary outcome measure - mGluR5 distribution volume ratio (DVR). A subgroup of 39 participants (16 MDD and 23 HC) completed proton magnetic resonance spectroscopy (1H MRS) to estimate anterior cingulate (ACC) glutamate, glutamine, and Glx (glutamate + glutamine) levels relative to creatine (Cr).
Results: No significant between-group differences were observed in mGluR5 VT or DVR. Compared to HC, individuals with MDD had higher ACC glutamate, glutamine, and Glx levels. Importantly, the ACC mGluR5 DVR negatively correlated with glutamate/Cr and Glx/Cr levels.
Conclusions: In this novel in vivo examination, we show an inverse relationship between mGluR5 availability and glutamate levels. These data highlight the need to further investigate the role of glutamatergic system in depression.
Keywords: 1H MRS; MDD; PET; [18F]FPEB; glutamate; mGluR5.
Figures

Similar articles
-
Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers.Transl Psychiatry. 2021 Jan 20;11(1):66. doi: 10.1038/s41398-020-01152-2. Transl Psychiatry. 2021. PMID: 33473111 Free PMC article.
-
Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.Biol Psychiatry. 2023 Jun 15;93(12):1099-1107. doi: 10.1016/j.biopsych.2022.10.018. Epub 2022 Nov 8. Biol Psychiatry. 2023. PMID: 36764853 Free PMC article.
-
Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study.Addict Biol. 2018 May;23(3):931-944. doi: 10.1111/adb.12542. Epub 2017 Sep 8. Addict Biol. 2018. PMID: 28884874
-
Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings.Neurosci Biobehav Rev. 2012 Jan;36(1):198-205. doi: 10.1016/j.neubiorev.2011.05.014. Epub 2011 Jun 6. Neurosci Biobehav Rev. 2012. PMID: 21672551 Review.
-
Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.Biol Psychiatry. 2018 Jul 15;84(2):95-105. doi: 10.1016/j.biopsych.2017.08.025. Epub 2017 Sep 19. Biol Psychiatry. 2018. PMID: 29100629 Free PMC article. Review.
Cited by
-
Metabotropic Glutamate Receptor Subtype 5 in Alcohol-Induced Negative Affect.Brain Sci. 2019 Jul 30;9(8):183. doi: 10.3390/brainsci9080183. Brain Sci. 2019. PMID: 31366097 Free PMC article. Review.
-
Predicting Antidepressant Effects of Ketamine: the Role of the Pregenual Anterior Cingulate Cortex as a Multimodal Neuroimaging Biomarker.Int J Neuropsychopharmacol. 2022 Dec 12;25(12):1003-1013. doi: 10.1093/ijnp/pyac049. Int J Neuropsychopharmacol. 2022. PMID: 35948274 Free PMC article.
-
Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers.Transl Psychiatry. 2021 Jan 20;11(1):66. doi: 10.1038/s41398-020-01152-2. Transl Psychiatry. 2021. PMID: 33473111 Free PMC article.
-
Nicotine Use and Metabotropic Glutamate Receptor 5 in Individuals With Major Depressive and Posttraumatic Stress Disorders.Chronic Stress (Thousand Oaks). 2023 Feb 9;7:24705470231154842. doi: 10.1177/24705470231154842. eCollection 2023 Jan-Dec. Chronic Stress (Thousand Oaks). 2023. PMID: 36843572 Free PMC article.
-
Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial.Psychopharmacol Bull. 2019 Feb 15;49(1):8-16. Psychopharmacol Bull. 2019. PMID: 30858635 Free PMC article. Clinical Trial.
References
-
- Mathers C, Fat DM, Boerma J. The global burden of disease: 2004 update. World Health Organization; 2008.
-
- Wieronska JM, Pilc A. Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs. Neurochem Int. 2009;55:85–97. - PubMed
-
- Krystal JH, Mathew SJ, D’Souza DC, Garakani A, Gunduz-Bruce H, Charney DS. Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs. 2010;24:669–693. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources